tw713
New Member
Posts: 13
|
Post by tw713 on Feb 3, 2019 11:52:13 GMT
Wondering what is everyone's thoughts on likelihood of success for Novavax (NVAX) P3 RSV results?Results are due soon (latest by end of Q1) Thanks
|
|
|
Post by nateb on Feb 3, 2019 17:43:11 GMT
I really need to revisit this one, thanks for the reminder. I will do some digging and let you know my opinion.
|
|
|
Post by JHam on Feb 4, 2019 14:01:45 GMT
Wondering what is everyone's thoughts on likelihood of success for Novavax (NVAX) P3 RSV results?Results are due soon (latest by end of Q1) Thanks Can you share any more detail about this stock?
|
|
|
Post by nateb on Feb 4, 2019 17:55:04 GMT
Wondering what is everyone's thoughts on likelihood of success for Novavax (NVAX) P3 RSV results?Results are due soon (latest by end of Q1) Thanks Based on what Im reading, Phase 3 data was already partially unblinded and vaccine efficacy has been assessed as somewhere between 40-100% effective. I think it stands a good shot(no pun intended) at being a good read out. Now how the market will react is anyone's guess. In most of the bios I have looked at the reaction to news good or bad has been a sell off. It is getting to the point to where I think rather than buying in before a catalyst it might now be better to buy in AFTER a catalyst, JMO.
|
|
|
Post by nateb on Mar 1, 2019 1:41:04 GMT
|
|